271 related articles for article (PubMed ID: 20653770)
1. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
2. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
5. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
6. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
[TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
Wang Z; Jinnin M; Nakamura K; Harada M; Kudo H; Nakayama W; Inoue K; Nakashima T; Honda N; Fukushima S; Ihn H
Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways.
Bogatkevich GS; Ludwicka-Bradley A; Highland KB; Hant F; Nietert PJ; Singleton CB; Silver RM
Arthritis Rheum; 2007 Oct; 56(10):3468-77. PubMed ID: 17907155
[TBL] [Abstract][Full Text] [Related]
11. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.
Ciechomska M; O'Reilly S; Suwara M; Bogunia-Kubik K; van Laar JM
PLoS One; 2014; 9(12):e115596. PubMed ID: 25549087
[TBL] [Abstract][Full Text] [Related]
12. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
[TBL] [Abstract][Full Text] [Related]
13. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
[TBL] [Abstract][Full Text] [Related]
14. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
Fineschi S; Reith W; Guerne PA; Dayer JM; Chizzolini C
FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of expression of extracellular matrix genes with siRNAs to Sparc and Ctgf in skin fibroblasts of CTGF transgenic mice.
Wang JC; Sonnylal S; Arnett FC; De Crombrugghe B; Zhou X
Int J Immunopathol Pharmacol; 2011; 24(3):595-601. PubMed ID: 21978691
[TBL] [Abstract][Full Text] [Related]
16. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y
J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
[TBL] [Abstract][Full Text] [Related]
17. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
20. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation.
Zhou XD; Xiong MM; Tan FK; Guo XJ; Arnett FC
Arthritis Rheum; 2006 Dec; 54(12):3885-9. PubMed ID: 17133596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
